Sorry, you need to enable JavaScript to visit this website.
Home About Programs & Policies Grants Competitive Grants

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    COVID-19 Vaccine Development for LMICs
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Improving Clinical Management for Patients with Breast Cancer in China
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    Advances in Migraine Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    2022/2023 Global Obesity ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Evolving Concepts in Biosimilar Optimization in Inflammatory Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Underlying medical conditions and other risk factors, higher risk of severe COVID-19 (European)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Building Capacity to Address Health Disparities in the US through AMS Telehealth and Tele-mentoring
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital USA
    2022/2023 Global NASH ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    2023 Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Antimicrobial Resistance Testing and Stewardship to Improve Hospitalized Patients’ Health Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pneumococcal Disease Prevention
    Release Date:
    Chronic Pain
    Release Date:
    Bacterial Infections
    Release Date:
    Pharmacy Pneumococcal Disease Prevention
    Release Date:
    Smoking Cessation
    Release Date:
    Non-Small Cell Lung Cancer
    Release Date:
    Cardiovascular Risk in Rheumatoid Arthritis
    Release Date:
    Opioid Pain
    Release Date:
    Adult Pneumococcal Disease Prevention
    Release Date:
    Prevention of Stroke in Women
    Release Date:
    Oncology Educational Needs Assessments
    Release Date:
    Extension Grant
    Release Date: